Valuation: IXICO plc

Market Cap 16.2M 21.48M 18.85M 17.72M 30.28M 2.06B 30.5M 213M 82.53M 1.05B 80.67M 78.9M 3.4B P/E 2026 *
-5.29x
P/E 2027 * -5.69x
Enterprise Value 6M 7.96M 6.99M 6.57M 11.22M 762M 11.3M 78.88M 30.58M 389M 29.89M 29.24M 1.26B EV / Sales 2026 *
0.75x
EV / Sales 2027 * 1.12x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 day-0.01%
1 week-1.35%
Current month-4.53%
1 month-4.53%
3 months-12.44%
6 months-5.14%
Current year-37.03%
1 week 7.08
Extreme 7.075
8
1 month 7
Extreme 7
8
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
19.5
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
-0.01%-1.35%-39.60%-61.86% 21.48M
+0.20%+3.56%+7.59%+30.62% 47.56B
-0.83%-0.36%+43.66%+34.77% 44.09B
-0.84%+4.86%+10.92%+91.52% 41.5B
-1.10%-2.64%+331.49%+535.80% 40.88B
-0.62%+0.11%+1.12%+46.02% 29.67B
-2.07%+0.12%+24.39%+154.30% 17.23B
+1.42%+0.47%+24.78%+41.10% 15.06B
-6.08%-9.92% - - 14.65B
-0.78%+9.46%-8.96% - 13.82B
Average -1.15%+0.49%+43.93%+109.03% 26.45B
Weighted average by Cap. -0.94%+0.96%+68.02%+141.24%

Financials

2026 *2027 *
Net sales 8M 10.61M 9.31M 8.75M 14.95M 1.02B 15.06M 105M 40.75M 518M 39.83M 38.95M 1.68B 9M 11.93M 10.47M 9.84M 16.82M 1.14B 16.94M 118M 45.84M 583M 44.81M 43.82M 1.89B
Net income -2.14M -2.84M -2.49M -2.34M -4M -272M -4.03M -28.15M -10.91M -139M -10.67M -10.44M -450M -2.8M -3.71M -3.26M -3.06M -5.23M -356M -5.27M -36.8M -14.27M -181M -13.94M -13.64M -588M
Net Debt -10.2M -13.52M -11.87M -11.16M -19.06M -1.3B -19.2M -134M -51.95M -660M -50.78M -49.67M -2.14B -6.1M -8.09M -7.1M -6.67M -11.4M -775M -11.48M -80.14M -31.07M -395M -30.37M -29.7M -1.28B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-09-24 GBX 7.399 -0.01% 6,710
26-09-23 GBX 7.400 -1.33% 235,066
26-09-22 GBX 7.500 0.00% 95,108
26-09-21 GBX 7.500 0.00% 143
26-09-18 GBX 7.500 0.00% 10,914
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0740GBP
Average target price
0.2600GBP
Spread / Average Target
+251.35%

Annual profits - Rate of surprise